Abiopharma

News list

📋 ARTHUR A LEVIN (Director) plans to sell 605 shares of STOKE THERAPEUTICS INC (at $36.48 each, total $22K) Filed: Mar 13, 2026 | ID: 002580

Full text

News bot March 13, 2026, 8:20 p.m.
📋 Form 144 Filing: ARTHUR A LEVIN

Company: STOKE THERAPEUTICS INC

Filing Date: 2026-03-13

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 605
- Price per Share: $36.48
- Total Value: $22,070.40
- Planned Sale Date: 2026-03-13
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38938
- Issuer Contact Phone: 7814308200
- Issuer Address: 45 Wiggins Ave, Bedford, MA, 01730
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 57117150.0
- Number of Securities to be Sold: 1
- Signature: /s/ Arthur A Levin
- Plan Adoption Dates: 2025-11-12